These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11853149)

  • 21. Evidence of the protective immunogenicity of native and recombinant Clostridium haemolyticum phospholipase C (beta toxin) in guinea pigs.
    Hauer PJ; Yeary TJ; Rosenbusch RF
    Vaccine; 2006 Jan; 24(2):124-32. PubMed ID: 16140435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
    Haas HF
    Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development, preparation and safety testing of a Clostridium welchii type C toxoid. I: preliminary observations in man in Papua New Guinea.
    Walker PD; Foster WH; Knight PA; Freestone DS; Lawrence G
    J Biol Stand; 1979; 7(4):315-23. PubMed ID: 231605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
    Hatheway CL
    Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of immune response stimulated in sheep, rabbits and guinea pigs by the administration of multi-component clostridial vaccines.
    Webster AC; Frank CL
    Aust Vet J; 1985 Apr; 62(4):112-4. PubMed ID: 3896219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Potency testing Clostridium novyi-containing bacterins: comparison of immunologic response in guinea pigs and sheep.
    Macheak ME; Claus KD; Maloy SE
    Am J Vet Res; 1972 Jun; 33(6):1201-8. PubMed ID: 5022400
    [No Abstract]   [Full Text] [Related]  

  • 28. Recombinant Lactobacillus casei expressing Clostridium perfringens toxoids α, β2, ε and β1 gives protection against Clostridium perfringens in rabbits.
    Zhao L; Guo Z; Liu J; Wang Z; Wang R; Li Y; Wang L; Xu Y; Tang L; Qiao X
    Vaccine; 2017 Jul; 35(32):4010-4021. PubMed ID: 28625525
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with recombinant bivalent chimera r-Cpae confers protection against alpha toxin and enterotoxin of Clostridium perfringens type A in murine model.
    Shreya D; Uppalapati SR; Kingston JJ; Sripathy MH; Batra HV
    Mol Immunol; 2015 May; 65(1):51-7. PubMed ID: 25645504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Factors modulating production of antibodies against Clostridium perfringens in mammals].
    Shemanova GF; Sergeeva TI; Panteleev EI; Vlasova EV; Dmitrieva LN
    Biull Eksp Biol Med; 1981 Sep; 92(9):322-5. PubMed ID: 6271303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
    Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
    Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
    Saleh N; Fathalla SI; Nabil R; Mosaad AA
    Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clostridium oedematiens: observations on potency assaying.
    Macheak ME
    Dev Biol Stand; 1976; 32():103-12. PubMed ID: 1001824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination with recombinant Clostridium perfringens toxoids α and β promotes elevated antepartum and passive humoral immunity in swine.
    Salvarani FM; Conceição FR; Cunha CE; Moreira GM; Pires PS; Silva RO; Alves GG; Lobato FC
    Vaccine; 2013 Aug; 31(38):4152-5. PubMed ID: 23845812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunization of guinea-pigs and cattle with a reduced dose Clostridium chauvoei vaccine produced in a semi-synthetic medium.
    Cameron CM; Botha WJ; Schoeman JH
    Onderstepoort J Vet Res; 1986 Mar; 53(1):51-3. PubMed ID: 3960492
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral immunity and injection-site reactions in cattle vaccinated with a multivalent clostridial vaccine administered via subcutaneous injection or via transdermal needle-free injection.
    Woolums AR; Ensley DT; Tanner PA; Fankhauser R; Shen J; Songer JG; Leard AT; Milward FW; Pence ME; Hurley DJ
    Am J Vet Res; 2011 Aug; 72(8):1124-9. PubMed ID: 21801072
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterologous protection against alpha toxins of Clostridium perfringens and Staphylococcus aureus induced by binding domain recombinant chimeric protein.
    Uppalapati SR; Kingston JJ; Murali HS; Batra HV
    Vaccine; 2014 May; 32(25):3075-81. PubMed ID: 24699467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Collaborative study for the validation of cell line assays for in-process toxicity and antigenicity testing of Clostridium septicum vaccine antigens - Part 1.
    Daas A; Behr-Gross ME; Bruckner L; Redhead K
    Pharmeur Bio Sci Notes; 2020; 2020():53-124. PubMed ID: 32589137
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunogenicity of isocomponents of the alpha-toxoid of Cl. oedematiens for mice of opposite reacting genotypes].
    Petrov RV; Shemanova GF; Panteleev EI; Dmitrieva LN; Tsvetkov VS
    Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):44-8. PubMed ID: 70913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.